Patent · US Active

Method to reduce loss of cardiac function following ischemia/reperfusion

US9023799B2 · kind B2 · utility

0Cited by

1References

7Claims

0Family size

Assignee

CELLMID LIMITED · AU

Inventors

Mitsuru Horiba · Ebeye, US
Itsuo Kodama · Ebeye, US
Takashi Muramatsu · Yokohama, JP
Kenji Kadomatsu · Nagoya, JP

Key dates

Filing date	Dec 6, 2005
Grant date	May 5, 2015
Priority date	—
Expiry date	Feb 6, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method to treat the chronic stage of heart injury after ischemia or reperfusion by administering Midkine to a subject in need of such treatment is described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.